Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Remodeling of the ribosomal quality control and integrated stress response by viral ubiquitin deconjugases

    The strategies adopted by viruses to reprogram the translation and protein quality control machinery and promote infection are poorly understood. Here, we report that the viral ubiquitin deconjugase (vDUB)—enc...

    Jiangnan Liu, Noemi Nagy, Carlos Ayala-Torres in Nature Communications (2023)

  2. Article

    Open Access

    Novel RICTOR amplification harbouring entities: FISH validation of RICTOR amplification in tumour tissue after next-generation sequencing

    Alterations in mTOR signalling molecules, including RICTOR amplification, have been previously described in many cancers, particularly associated with poor prognosis. In this study, RICTOR copy number variation (...

    Dániel Sztankovics, Ildikó Krencz, Dorottya Moldvai, Titanilla Dankó in Scientific Reports (2023)

  3. Article

    Open Access

    Establishing a Dignity Scale - Measuring Intrinsic Value within Social Contexts

    In this paper we describe the basics of the measurement of human dignity at the individual level, as well as within social contexts such as teams and organizations. In accordance with the prevailing literature...

    Michael Pirson, Ralph L. Piedmont, Noemi Nagy, Donna Hicks in Humanistic Management Journal (2023)

  4. No Access

    Chapter and Conference Paper

    The Case of David vs. Goliath?

    Noémi Nagy in Threats to Peace and International Security: Asia versus West (2023)

  5. Article

    Open Access

    Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells

    Tyrosine kinase inhibitor (TKI) treatment has dramatically improved the survival of chronic myeloid leukemia (CML) patients, but measurable residual disease typically persists. To more effectively eradicate le...

    Alena Malyukova, Dorina Ujvari, Elham Yektaei-Karin, Ana Zovko in Cell Death & Disease (2021)

  6. Article

    Open Access

    Publisher Correction to: Direct contact between Plasmodium falciparum and human B-cells in a novel co-culture increases parasite growth and affects B-cell growth

    Sreenivasulu B. Reddy, Noemi Nagy, Caroline Rönnberg, Francesca Chiodi in Malaria Journal (2021)

  7. Article

    Open Access

    Direct contact between Plasmodium falciparum and human B-cells in a novel co-culture increases parasite growth and affects B-cell growth

    Plasmodium falciparum parasites cause malaria and co-exist in humans together with B-cells for long periods of time. Immunity is only achieved after repeated exposure. There has been a lack of methods to mimic th...

    Sreenivasulu B. Reddy, Noemi Nagy, Caroline Rönnberg, Francesca Chiodi in Malaria Journal (2021)

  8. Article

    Open Access

    Immune cells lacking Y chromosome show dysregulation of autosomal gene expression

    Epidemiological investigations show that mosaic loss of chromosome Y (LOY) in leukocytes is associated with earlier mortality and morbidity from many diseases in men. LOY is the most common acquired mutation a...

    Jan P. Dumanski, Jonatan Halvardson, Hanna Davies in Cellular and Molecular Life Sciences (2021)

  9. Article

    Open Access

    Correction: The Epstein–Barr virus nuclear antigen-1 upregulates the cellular antioxidant defense to enable B-cell growth transformation and immortalization

    This article was originally published under Springer Nature’s License to Publish, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the paper have been modified accordingly.

    Jiayu Wang, Noemi Nagy, Maria G. Masucci in Oncogene (2020)

  10. Article

    Open Access

    The Epstein–Barr virus nuclear antigen-1 upregulates the cellular antioxidant defense to enable B-cell growth transformation and immortalization

    Epstein–Barr virus (EBV) immortalizes human B-lymphocytes and is implicated in the pathogenesis of lymphoid and epithelial cell malignancies. The EBV nuclear antigen (EBNA)-1 induces the accumulation of reacti...

    Jiayu Wang, Noemi Nagy, Maria G. Masucci in Oncogene (2020)

  11. No Access

    Article

    The Effects of Different mTOR Inhibitors in EGFR Inhibitor Resistant Colon Carcinoma Cells

    Several monoclonal antibodies and inhibitors targeting signalling pathways are being used in personalised medicine. Anti-EGFR antibodies seem to be effective, however, therapy resistance often occurs in colon ...

    Tamás Sticz, Anna Molnár, Titanilla Dankó, Zoltán Hujber in Pathology & Oncology Research (2019)

  12. Article

    Open Access

    Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells

    Glioma is the most common highly aggressive, primary adult brain tumour. Clinical data show that therapeutic approaches cannot reach the expectations in patients, thus gliomas are mainly incurable diseases. Tu...

    Gábor Petővári, Zoltán Hujber, Ildikó Krencz, Titanilla Dankó in Cancer Cell International (2018)

  13. Article

    Open Access

    Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma

    Synovial sarcoma is a rare soft tissue tumor which contains the unique SS18-SSX1, SS18-SSX2 – or, rarely, SS18-SSX4 - fusion transcripts. It is well known that some soft tissue tumors, like Ewing sarcomas and ...

    Dóra Mihály, Noémi Nagy, Gergő Papp, Zsuzsanna Pápai, Zoltán Sápi in Diagnostic Pathology (2018)

  14. No Access

    Chapter

    Language Diversity as a Source of Conflict in Hungary—Possible Implications of Immigration

    Hungary has been a multinational and multilingual state for a thousand years, therefore had to implement policies and legislation on its minorities and linguistic diversity. After the democratic transition in ...

    Noemi Nagy in Cross-Cultural Dialogue as a Conflict Management Strategy (2018)

  15. Article

    Open Access

    Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells

    Multiple studies concluded that oncometabolites (e.g. D-2-hydroxyglutarate (2-HG) related to mutant isocitrate dehydrogenase 1/2 (IDH1/2) and lactate) have tumour promoting potential. Regulatory mechanisms implic...

    Zoltán Hujber, Gábor Petővári in Journal of Experimental & Clinical Cancer … (2017)

  16. No Access

    Protocol

    Mice with Reconstituted Human Immune System Components as a Tool to Study Immune Cell Interactions in EBV Infection

    Recent developments in mouse models that harbor part of a human immune system have proved extremely valuable to study the in vivo immune response to human specific pathogens such as Epstein-Barr virus. Over th...

    Frank Heuts, Noemi Nagy in Epstein Barr Virus (2017)

  17. No Access

    Protocol

    Establishment of EBV-Infected Lymphoblastoid Cell Lines

    Lymphoblastoid cell lines (LCLs) can be generated easily by in vitro EBV infection of B lymphocytes collected from any individual. In vitro, these EBV-infected B cell cultures yield proliferating, transformed ...

    Noemi Nagy in Epstein Barr Virus (2017)

  18. No Access

    Reference Work Entry In depth

    Career Development and Aging

    Noemi Nagy, Claire S. Johnston, Andreas Hirschi in Encyclopedia of Geropsychology (2017)

  19. No Access

    Article

    Growth inhibitory effect of rapamycin in Hodgkin-lymphoma cell lines characterized by constitutive NOTCH1 activation

    Growing evidence suggests that deregulation of signalling elements of Notch and mammalian target of rapamycin (mTOR) pathways contribute to tumorigenesis. These signals play important roles in cellular functio...

    Noémi Nagy, Melinda Hajdu, Ágnes Márk, Péter Attila Király, Mónika Tóth in Tumor Biology (2016)

  20. No Access

    Article

    Expression of Certain Leukemia/Lymphoma Related microRNAs and its Correlation with Prognosis in Childhood Acute Lymphoblastic Leukemia

    In spite of the improved efficacy of therapy, it still fails in 15–20 % of childhood acute lymphoblastic leukemia (ALL) patients. Recently, altered expression of certain miRNAs (miRs) have been described in AL...

    Karolina Nemes, Monika Csóka, Noémi Nagy, Ágnes Márk in Pathology & Oncology Research (2015)

previous disabled Page of 2